CI Cigna Group
Hospital & Medical Service Plans · NYSE · SEC CIK 1739940 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $73.68B | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B |
| Cost of revenue | $58.59B | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B |
| SG&A expense | $3.61B | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B |
| Operating income | $2.40B | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B |
| Interest expense | $356.00M | $359.00M | $357.00M | $300.00M | $363.00M | $338.00M | $362.00M | $400.00M |
| Pretax income | $2.10B | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | $1.65B | $2.01B |
| Income tax | $401.00M | $382.00M | $409.00M | $543.00M | $322.00M | $389.00M | $239.00M | $473.00M |
| Net income | $1.44B | $1.66B | $1.65B | $1.23B | $1.87B | $1.53B | $1.32B | $1.42B |
| EBITDA | $3.26B | $3.33B | $3.01B | $3.07B | $3.27B | $2.99B | $2.65B | $2.82B |
| EPS (basic) | 5.49 | 6.31 | 6.30 | — | 7.02 | 5.76 | 4.88 | — |
| EPS (diluted) | 5.47 | 6.29 | 6.26 | — | 6.98 | 5.71 | 4.85 | — |
| Dividends declared per share | 1.56 | 1.56 | 1.56 | 1.51 | 1.51 | 1.51 | 1.51 | 1.40 |
| Weighted avg. shares (diluted) | 263.79M | 263.96M | 264.02M | — | 267.53M | 268.15M | 272.95M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $6.19B | $6.30B | $7.04B | $7.68B | $6.07B | $4.39B | $8.38B | $7.55B |
| Short-term investments | $1.11B | $959.00M | $812.00M | $1.06B | $883.00M | $813.00M | $727.00M | $665.00M |
| Receivables | $31.49B | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B |
| Inventory | $5.55B | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B |
| Current assets | $47.23B | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B |
| PP&E, net | $3.74B | $3.74B | $3.70B | $3.65B | $3.65B | $3.62B | $3.68B | $3.65B |
| Goodwill | $45.54B | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B |
| Intangibles | $26.75B | $26.93B | $27.32B | $28.56B | $28.98B | $28.67B | $29.05B | $29.42B |
| Total assets | $157.64B | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B |
| Current liabilities | $56.03B | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B |
| Short-term debt | $2.29B | $2.79B | $1.53B | $592.00M | $3.09B | $4.29B | $3.99B | $3.04B |
| Long-term debt | $28.85B | $29.09B | $29.37B | $30.87B | $30.95B | $26.48B | $26.45B | $28.94B |
| Total debt | $31.14B | $31.88B | $30.90B | $31.46B | $34.04B | $30.77B | $30.45B | $31.97B |
| Total liabilities | $113.92B | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B |
| Shareholders' equity | $43.38B | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B |
| Net debt | $24.96B | $25.58B | $23.86B | $23.79B | $27.97B | $26.38B | $22.07B | $24.42B |
| Shares outstanding | — | — | — | 263.46M | — | — | — | 273.79M |
| Cash flow statement | ||||||||
| Operating cash flow | $2.57B | -$421.00M | $1.13B | $6.15B | $3.42B | -$1.89B | $1.92B | $5.21B |
| Investing cash flow | -$1.27B | -$503.00M | -$637.00M | -$420.00M | -$4.39B | -$797.00M | $1.20B | -$191.00M |
| Financing cash flow | -$1.44B | $207.00M | -$1.14B | -$4.07B | $2.66B | -$1.33B | -$3.68B | -$3.25B |
| Depreciation & amortization | $867.00M | $655.00M | $650.00M | $722.00M | $697.00M | $682.00M | $674.00M | $646.00M |
| Dividends paid | $410.00M | $409.00M | $417.00M | $396.00M | $402.00M | $401.00M | $412.00M | $384.00M |
| Share buybacks | $251.00M | $280.00M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B |
Free plan shows the latest 8 periods; Pro shows all 39 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.